Pulse Biosciences (PLSE) Leases (2019 - 2025)

Pulse Biosciences has reported Leases for 7 years, with the latest figure at $6.0 million in Q4 2025.

• For the quarter ending Q4 2025, Leases fell 16.1% year-over-year to $6.0 million; the trailing twelve-month figure through Dec 2025 stood at $6.0 million (down 16.1% YoY), and the FY2025 full-year result was $6.0 million, down 16.1% from the prior year.
• Leases for Q4 2025 stood at $6.0 million, down from $6.3 million in the prior quarter.
• The five-year high for Leases was $9.3 million in Q1 2021, with the low at $6.0 million in Q4 2025.
• Average Leases over 5 years is $7.6 million, with a median of $7.4 million recorded in 2021.
• Peak annual rise in Leases reached 84.02% in 2021, while the deepest fall reached 23.12% in 2021.
• Tracing PLSE's Leases over 5 years: stood at $7.3 million in 2021, then advanced by 11.11% to $8.1 million in 2022, then declined by 10.0% to $7.3 million in 2023, then slipped by 1.28% to $7.2 million in 2024, then declined by 16.1% to $6.0 million in 2025.
• The last three Leases figures came in at $6.0 million (Q4 2025), $6.3 million (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.

Peer Comparison